Retrospective Examination of Initial Care of Severe Bacterial Infections of the Child

Overview

The aim of the study is to determine the frequency of sub-optimal care in the initial care (before arrival at the intensive care unit) of children from "West France regions" suffering of severe bacterial infections.The characteristic "optimal or not" of the initial medical care will be determined by 2 independent experts, blinded from each other and blinded from the issue of the care. In case of a discordance between the two experts, a third expert will be demanded. Three possibilities of conclusion will be proposed to the experts: "sure sub-optimal medical care", "possible suboptimal care" and "optimal care".

Full Title of Study: “Frequency, Consequences and Determinants of Sub-optimal Care in the Initial Care of Severe Bacterial Infections of the Child”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: N/A
    • Intervention Model: Single Group Assignment
    • Primary Purpose: Health Services Research
    • Masking: None (Open Label)
  • Study Primary Completion Date: January 2014

Interventions

  • Other: Retrospective examination by experts whether care given fo child admitted at the ICU for suspicion of bacterial infection (not nosocomial) was optimal or not
    • When child is admitted at Intensive Care Unit (ICU) for suspicion of bacterial infection that is not nosocomial, data on child’s infection and cares received, is completed on an electronic Case Report Form (e-CRF) by Doctor of ICU. Characteristic “optimal or not” of initial medical care is then determined by the independent experts blinded from issue of the care.

Clinical Trial Outcome Measures

Primary Measures

  • Frequency of optimal care and of non optimal care in the initial care (before arrival at the intensive care unit) of children (from West France regions) suffering of severe bacterial infections.
    • Time Frame: 1day
    • For each child medical file, the verdict “optimal care” or the verdict ” non optimal care” will be determined by two independent experts, blinded from each other. If verdict base their judgement through recommendations listed in the literature.

Secondary Measures

  • characteristics of sub-optimal cares
    • Time Frame: 1 day
    • Experts will explain their verdict by answering to a list of questions. These questions will allow to identify and classify characteristics of defaults of cares .
  • determinants of sub-optimal cares
    • Time Frame: 1 day
    • To identify determinants of sub-optimal cares (examples : place of medical care, qualification and experience of the Medical Doctor, moment of medical care.
  • consequences of initial sub-optimal cares
    • Time Frame: 1 day
    • To identify consequences of initial sub-optimal cares on the outcome of children with severe bacterial infections (child death, etc).

Participating in This Clinical Trial

Inclusion Criteria

  • Child from West France regions – Aged between 1 month and 16 years old, – Admitted at the intensive care unit for a severe bacterial infection and with the first symptoms appeared when child was at home or hospitalized since less than 48h – Children dead at home will also be included in this study via the mobil medical urgency help unit (french term : "SAMU") Exclusion Criteria:

  • Patient not fulfilling inclusion criteria – Child with a nosocomial infection – Child dead or admitted at the intensive care unit following a pertussis- Child not admitted at the intensive care or not dead at home in a context of infection. – Child with viral or fungic infection admitted at the intensive care unit.

Gender Eligibility: All

Minimum Age: 1 Month

Maximum Age: 16 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Nantes University Hospital
  • Provider of Information About this Clinical Study
    • Sponsor

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.